Al Luderer

Albert Luderer has over four decades of successful experience in biotechnology, with special focuses on technology, business development and the commercialization of multiple tools and services currently in clinical use.

Dr. Luderer is CEO and board director of molecular therapeutics and imaging company Indi Molecular. He is also a board director of publicly traded Binano Genomics, a genome analysis company providing diagnostic tools and services.

Dr. Luderer previously served as CEO and board director of personalized diagnostics company Integrated Diagnostics, acquired by Biodesix which leveraged the Nodify Lung asset to a successful IPO. Prior to his role with Indi, Dr. Luderer was president and CEO of BioTrove, a venture-backed molecular biological tools company acquired by Life Technologies.

Additionally, Dr. Luderer was CEO of venture-backed therapeutics company Light Sciences and president and COO of bioMérieux, Inc. He held senior management positions at DIANON Systems (LabCorp), Boehringer Mannheim (Roche), and Ciba-Corning rounding out Dr. Luderer’s experience in the industry.

He earned his PhD from Rutgers University, where he was a National Science Foundation predoctoral fellow, and performed postgraduate work in immunology at Jefferson Medical College.